Sol-Gel Technologies
Pre-Approval PRO BETAStale Activity
No new clinical trials started in 2+ years. Activity may be declining or company may be focusing on existing programs. Last trial started: 3/17/2024
Pipeline by Phase
Therapeutic Focus
Clinical Trials (15)
Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome
Started: 3/17/2024
Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome)
Started: 6/3/2020
Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome (Gorlin Syndrome)
Started: 2/19/2019
A Study of S6G5T-3 in the Treatment of Acne Vulgaris
Started: 12/21/2018
A Study of S6G5T3 in the Treatment of Acne Vulgaris
Started: 12/14/2018
A Study of S5G4T-1 in the Treatment of Papularpustular Rosacea
Started: 6/21/2018
A Long-Term Safety Study of S5G4T-1 in the Treatment of Papulopustular Rosacea
Started: 9/12/2018
A Study of S5G4T-1 in the Treatment of Papulopustular Rosacea
Started: 6/18/2018
Bioequivalence Study to Compare Sol-Gel Technologies' 5-FU Cream With Efudex® (5-FU) Cream
Started: 12/21/2018
An Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCC
Started: 12/20/2019
Efficacy and Safety of Product S2G6T-1in Patients With Symptomatic Inflammatory Interdigital Tinea Pedis
Started: 9/1/2016
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris
Started: 5/1/2016
Evaluation of Topical Encapsulated Benzoyl Peroxide on the Skin Microbiome and Skin Biophysical Properties
Started: 6/10/2020
MUSE Study to Evaluate the Pharmacokinetics, Safety and Tolerability of S6G5T-3
Started: 6/27/2019